Mert Aktar - 21 Oct 2024 Form 3 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Director
Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
21 Oct 2024
Net transactions value
$0
Form type
3
Filing time
24 Oct 2024, 06:02:48 UTC
Next filing
02 Jun 2025

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney